e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Comorbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The blue bloater phenotype in COPD is associated with metabolic syndrome
F. Flores-Trujillo, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, J. Regalado-Pineda, R. H. Sansores-Martinez (Mexico City DF, Mexico)
Source:
Annual Congress 2008 - Comorbidities in COPD
Session:
Comorbidities in COPD
Session type:
E-Communication Session
Number:
4508
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Flores-Trujillo, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, J. Regalado-Pineda, R. H. Sansores-Martinez (Mexico City DF, Mexico). The blue bloater phenotype in COPD is associated with metabolic syndrome. Eur Respir J 2008; 32: Suppl. 52, 4508
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Imaging of complicated pneumonia: what is new?
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
The association between metabolic syndrome, obesity and asthma
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008
Evaluation of association between COPD and metabolic syndrome, and insulin resistance
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Prevalence of metabolic syndrome in smokers with and without COPD
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008
Asthma-COPD overlap syndrome shows favorable prognosis compared to pure COPD in Korean COPD cohort
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
The asthma–COPD overlap syndrome
Source: Eur Respir Monogr 2015; 69: 85-95
Year: 2015
Metabolic syndrome in patients with stable COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Do respiratory patients with chronic hypoxaemia favour the colour blue?
Source: Eur Respir J 2006; 28: Suppl. 50, 863s
Year: 2006
Prevalence of the metabolic syndrome (MS) in mediterranean patients with suspected OSAS
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
Metabolic syndrome and COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
The lack of evidence based knowledge of metabolic syndrome in obesity hypoventilation syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Clinical differences of COPD patients with and without metabolic syndrome
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
What constituents of the metabolic syndrome are prevalent in the sleep apnoea syndrome?
Source: Eur Respir J 2005; 26: Suppl. 49, 568s
Year: 2005
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The clinical and genetic features of COPD-asthma overlap syndrome
Source: Eur Respir J 2014; 44: 341-350
Year: 2014
Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Metabolic syndrome and chronic diseases in COPD
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept